Clinical Trials Logo

Myofascial Pain Syndromes clinical trials

View clinical trials related to Myofascial Pain Syndromes.

Filter by:

NCT ID: NCT00489073 Completed - Fibromyalgia Clinical Trials

Duloxetine Versus Placebo for Fibromyalgia

Start date: November 2002
Phase: Phase 3
Study type: Interventional

The primary purpose of this study is to determine if duloxetine reduces pain severity in patients with fibromyalgia.

NCT ID: NCT00482859 Completed - Clinical trials for Fibromyalgia Syndrome

Sleep Disturbance and Sleep Quality in Women With Fibromyalgia Syndrome

Start date: April 2007
Phase: N/A
Study type: Observational

The purpose of this week long study is to describe sleep and problems with sleep in women diagnosed with Fibromyalgia syndrome.

NCT ID: NCT00468013 Completed - Fibromyalgia Clinical Trials

A Computer-Based Intervention for Medically Unexplained Physical Symptoms

Start date: March 2007
Phase: N/A
Study type: Interventional

In this study 60 people with medically unexplained physical symptoms (MUPS) will receive either a 6-session resilience skill building intervention provided fully online or a weekly computerized journaling assignment. Both programs can be completed from home. Participants will complete questionnaires both before and after the intervention and changes in symptoms, mood and satisfaction with life will be assessed.

NCT ID: NCT00464737 Completed - Clinical trials for Fibromyalgia Syndrome

The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults.

SP888
Start date: March 2007
Phase: Phase 2
Study type: Interventional

This trial is to investigate the efficacy and safety of rotigotine as compared to placebo in reducing signs and symptoms of fibromyalgia syndrome. The effects of rotigotine on pain, sleep, general activity, mood, and quality of life, and the use of rescue medication to treat pain will be assessed.

NCT ID: NCT00447083 Completed - Clinical trials for Fibromyalgia Syndrome

Benefits of Tanning in Fibromyalgia Patients

Start date: May 2005
Phase: N/A
Study type: Interventional

- To establish whether ultraviolet light exposure acutely reduces perceptions of pain in patients with fibromyalgia. - To establish whether a series of UV light exposures has a cumulative effect on fibromyalgia pain.

NCT ID: NCT00437411 Completed - Fibromyalgia Clinical Trials

Healing Through Affective Self-Awareness in Fibromyalgia: a Randomized Controlled Trial

Start date: April 2007
Phase: N/A
Study type: Interventional

The investigators are studying whether a brief three-session mind-body workshop helps people with fibromyalgia. The investigators hypothesize that this workshop will significantly improve pain and other symptoms, compared to usual care.

NCT ID: NCT00436033 Completed - Clinical trials for Fibromyalgia Syndrome

A Multicentre Trial to Determine the Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia Syndrome

Start date: February 2006
Phase: Phase 3
Study type: Interventional

Investigation of efficacy and safety of treatment with milnacipran in the treatment of fibromyalgia syndrome.

NCT ID: NCT00424892 Completed - Fibromyalgia Clinical Trials

Study Evaluating DVS SR in Patients With Fibromyalgia Syndrome

Start date: n/a
Phase: Phase 2/Phase 3
Study type: Interventional

The primary objective is to evaluate the long-term safety of desvenlafaxine succinate sustained-release (DVS SR) during open-label treatment in adult outpatients with fibromyalgia syndrome.

NCT ID: NCT00423813 Completed - Fibromyalgia Clinical Trials

A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.

Start date: December 2006
Phase: Phase 3
Study type: Interventional

The objective of this trial is to evaluate the safety and efficacy of Xyrem® compared to placebo for the treatment of fibromyalgia in a randomized, double blind, placebo controlled, parallel group trial.

NCT ID: NCT00423631 Completed - Fibromyalgia Clinical Trials

Web-based Education to Enhance Fibromyalgia Management

Start date: September 2006
Phase: N/A
Study type: Interventional

Fibromyalgia (FMS) a condition marked by pain, fatigue, and memory complaints, is considered a chronic condition and is most commonly treated or managed using medications. Previous studies have found benefit in adding cognitive-behavioral therapy (CBT), a non-medication intervention, to standard care in order to obtain better outcomes in terms of improved functional status and symptom reduction. While the addition of CBT to standard care has been shown to be beneficial, it is not a form of therapy that is widely available to patients with FMS. CBT includes a variety of skills that can be taught to patients to help in the management of chronic illnesses. This protocol will examine the relative merits of providing these CBT skills to patients via an informational website. The website will contain the content of CBT, a social support capability, and data transfer capabilities. The addition of this website to standard care will be compared to standard care alone. This study is interested in assessing improvements in physical functional status, the symptoms of FMS, and the relative costs of the interventions as compared to the savings in health care utilization over a 6-month period. Primary Hypothesis The primary hypothesis of this study is that the number of patients with fibromyalgia who are able to achieve clinically meaningful improvements in physical function will be greater when standard symptom-based pharmacological care is augmented by CBT skills delivered through an educational website. Secondary Hypotheses 1. The proportion of patients with fibromyalgia who are able to achieve clinically meaningful improvements in symptoms of FMS such as pain, fatigue, and perceived cognitive difficulties will be greater when standard symptom-based pharmacological care is augmented by CBT skills delivered through an educational website 2. The proportion of patients with fibromyalgia who are able to achieve clinically meaningful improvements in mood and beliefs about pain will be greater when standard symptom-based pharmacological care is augmented by CBT skills delivered through an educational website